Dividend/BonusRecord Date
Lincoln Pharma has set September 11, 2026, as the Record Date for its 32nd Annual General Meeting.
Lincoln Pharmaceuticals LimitedLINCOLN · Filed with the exchange
Shareholders holding shares by this date will be eligible for a final dividend of ₹1.80 per share (18% of face value) for FY2025-26, pending approval at the AGM on September 30, 2026. Book closure is from September 12-30, 2026.
No comments yet. Be the first.